ADCT
Adc Therapeutics SA

1,247
Mkt Cap
$536.1M
Volume
69,729.00
52W High
$4.80
52W Low
$1.05
PE Ratio
-2.92
ADCT Fundamentals
Price
$4.15
Prev Close
$4.24
Open
$4.22
50D MA
$3.82
Beta
1.49
Avg. Volume
772,271.51
EPS (Annual)
-$1.62
P/B
-2.00
Rev/Employee
$267,309.43
$65.48
Loading...
Loading...
News
all
press releases
ADC Therapeutics (NYSE:ADCT) Sees Strong Trading Volume - Here's What Happened
ADC Therapeutics (NYSE:ADCT) Sees Strong Trading Volume - What's Next...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of "Moderate Buy" from Brokerages
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five analysts that are presently covering the firm, MarketBeat reports. One research...
MarketBeat·1d ago
News Placeholder
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference...
PR Newswire·2d ago
News Placeholder
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland, March 2, 2026 LAUSANNE...
PR Newswire·3d ago
News Placeholder
ADC Therapeutics to Participate in March Investor Conferences
ADC Therapeutics to Participate in March Investor Conferences ADC Therapeutics to Participate in March Investor Conferences PR Newswire LAUSANNE, Switzerland, Feb. 24, 2026 LAUSANNE, Switzerland...
PR Newswire·9d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Shares Up 6.7% - Time to Buy?
ADC Therapeutics (NYSE:ADCT) Trading 6.7% Higher - What's Next...
MarketBeat·10d ago
News Placeholder
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement PR Newswire LAUSANNE, Switzerland, Feb. 23, 2026...
PR Newswire·10d ago
News Placeholder
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of ADC Therapeutics SA (NYSE:ADCT - Get Free Report) have received an average rating of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat.com reports. One equities...
MarketBeat·26d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's What Happened
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's Why...
MarketBeat·27d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - Here's Why
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - What's Next...
MarketBeat·27d ago
<
1
2
...
>

Latest ADCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.